What You Should Know:
– Dexcom, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for individuals over the age of 18…
Continue Reading
Maria Vassileva, PhD, Chief Science and Regulatory Officer for DIA
Stephanie Rosner, Scientific Program Manager, Artificial Intelligence for DIA
Imagine a physician and a patient sitting quietly together in an examination room. The physician’s eyes are focused…
Continue Reading
– A recent study has shed light on the significant potential of the ECHO Model in improving diabetes care in rural communities.
– The research, published in The Journal of General Internal Medicine, showed that…
Continue Reading
While clinician burnout is well known, “patient burnout” within the chronic disease population is an equally critical but silent issue. Managing chronic conditions, especially diabetes, is complex and overwhelming. Nonadherence affects 12% of the…
Continue Reading
Truvian Health, maker of a benchtop blood testing system, announced it secured $74 million in capital and is partnering with Canada’s largest pharmacy, Shoppers Drug Mart. Great Point Ventures and Wittington Ventures co-led the round,…
Continue Reading
Payers are always wary about funding new treatments for illnesses and conditions: When millions of dollars are at stake, payers want demonstrated improvements in outcomes. So do doctors and patients, before they go through…
Continue Reading
